Beat R. Merz
Vorsitzender bei MiniNaviDent AG
Ursprung des Netzwerks ersten Grades von Beat R. Merz
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
HBM Partners AG
HBM Partners AG Investment ManagersFinance HBM Partners AG (HBM-P) was established in 2001 as an independent provider of investment advisory services with headquarters in Zug, Switzerland. HBM-P's field of expertise comprises global human medicine, biotechnology, medical technology and related sectors. The firm primarily advises HBM BioVentures AG and HBM BioCapital via their Cayman Islands-based, wholly-owned subsidiary, HBM Partners (Cayman) Ltd., which acts as the investment manager for the HBM funds. They rely on the services of an external consultant to analyze investment opportunities in the US.
8
| Private Company | Investment Managers | 8 |
MiniNaviDent AG
MiniNaviDent AG Medical SpecialtiesHealth Technology MiniNaviDent AG develops dental equipment. It develops miniaturized navigation system, which is directly fitted to the surgical handpiece, and which guides the drill in real-time and in 3D to the correct implant position and angle using a ceramic dual-mode-marker and proprietary algorithms. The company was founded in 2013 by Frank Berlinghoff, Philipp Jürgens, Hans-Florian Zeilhofer and Erik Schkommodau and is headquartered in Basel, Switzerland.
7
| Holding Company | Medical Specialties | 7 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Beat R. Merz
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
Neusentis, Inc.
Neusentis, Inc. Pharmaceuticals: MajorHealth Technology Neusentis is a biopharmaceutical company, which is focused on the discovery, development and commercialization of novel orally-administered small molecule drugs that modulate ion channel targets. The company has developed an integrated technology platform that allows for the efficient discovery of drug leads. The firm is conducting research and development activities in a number of disease areas, including epilepsy, pain and inflammation. Icagen has two clinical stage programs in epilepsy and pain. The company was formerly known as Icagen, Inc. It was founded by Andre L. Lamotte and P. Kay Wagoner on November 23, 1992 and is headquartered in Durham, NC. | Pharmaceuticals: Major | Founder | |
CHEMOCENTRYX, INC. | Pharmaceuticals: Major | Director/Board Member | |
Symbiomix Therapeutics LLC
Symbiomix Therapeutics LLC BiotechnologyHealth Technology Symbiomix Therapeutics LLC develops medicines for women’s health infections and related diseases. It offers SYM-1219, a drug that contains secnidazole that facilitate administration as a single-dose oral therapy for various women's health infections including bacterial vaginosis. The company was founded by Jack Roberts, Steve Pomerantz and Joseph L. Amprey III in 2012 and is headquartered in Newark, NJ. | Biotechnology | Director/Board Member | |
SIEGFRIED HOLDING AG | Pharmaceuticals: Major | Director/Board Member | |
MS INDUSTRIE AG | Electronic Equipment/Instruments | Director/Board Member | |
SETECH, Inc.
SETECH, Inc. Miscellaneous Commercial ServicesCommercial Services SETECH, Inc. provides consulting and engineering services. The private company is based in Madison, TN. The CEO of the company is William Shriver. | Miscellaneous Commercial Services | Director/Board Member | |
HBM HEALTHCARE INVESTMENTS AG | Investment Managers | Chief Executive Officer Corporate Officer/Principal Director of Finance/CFO | |
University of Central Florida | College/University | Graduate Degree | |
ESBATech, a Novartis Co. GmbH
ESBATech, a Novartis Co. GmbH Miscellaneous Commercial ServicesCommercial Services ESBATech AG develops antibody fragment therapeutics. The firm's antibody fragment is derived from human antibody fragment scaffolds. It develops Immuna, an antigen-independent platform to screen, select, and optimize highly-stable and soluble, single-chain antibody fragments. The company was founded by Dominik Escher in September 1998 and is headquartered Schlieren, Switzerland. | Miscellaneous Commercial Services | Director/Board Member | |
University of Basel | College/University | Doctorate Degree Graduate Degree | |
University of Zurich | College/University | Doctorate Degree Masters Business Admin | |
Freie Universität Berlin | College/University | Doctorate Degree | |
University of Bern | College/University | Doctorate Degree Doctorate Degree | |
BIOATLA, INC. | Biotechnology | Director/Board Member | |
Neurelis, Inc.
Neurelis, Inc. Pharmaceuticals: MajorHealth Technology Neurelis, Inc. operates as a specialty pharmaceutical company. It is organized to license, develop and commercialize product candidates for the treatment of central nervous system disorders with a focus on the acute treatment of epilepsy and anxiety episodes. The company was founded by Craig C. Chambliss and David F. Hale in 2007 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member | |
Sudpack Medica
Sudpack Medica Containers/PackagingProcess Industries Sudpack Medica designs and manufactures medical plastic packaging solutions. The private company is based in Baar, Switzerland. | Containers/Packaging | Director/Board Member | |
AGI AG FÜR Isolierungen | Chairman | ||
SE Swiss Equities AG
SE Swiss Equities AG Pharmaceuticals: OtherHealth Technology SE Swiss Equities AG is an investment company with a focus on the pharmaceutical industry. The private company is based in Zurich, Switzerland. Reto A. Garzetti has been the CEO of the company since 1998. | Pharmaceuticals: Other | Director/Board Member | |
Schweizer Verband der Investmentgesellschaften | Chairman | ||
Advanced Osteotomy Tools - AOT AG
Advanced Osteotomy Tools - AOT AG Medical SpecialtiesHealth Technology Advanced Osteotomy Tools-AOT AG develops, manufactures, and markets medical devices and tools for bone-cutting. Its device combines three-dimensional (3D) pre-operative planning and a navigation system with a miniaturized laser mounted on a robotic arm. The company was founded by Alfredo E. Bruno, Philippe Cattin, Philipp Jürgens, and Hans-Florian Zeilhofer in 2011 and is headquartered in Allschwil, Switzerland. | Medical Specialties | Founder | |
Galecto Biotech ApS
Galecto Biotech ApS Pharmaceuticals: MajorHealth Technology Galecto Biotech ApS provides galectin modulators for the treatment of severe diseases, including fibrosis and cancer. Its products include galectin-3 inhibitors, fibrosis and literature. The company was founded by Tariq Sethi, Hans Thalsgard Schambye, Ulf Jorgen Nilsson, and Hakon Leffler in 2011 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Director/Board Member | |
HBM Healthcare Investments (Cayman) Ltd.
HBM Healthcare Investments (Cayman) Ltd. Hospital/Nursing ManagementHealth Services Part of HBM Partners AG, HBM Healthcare Investments (Cayman) Ltd. provides healthcare services. The company is based in George Town, Cayman Islands. Andreas Wicki has been the CEO of the company since 2001. | Hospital/Nursing Management | Chief Executive Officer Director/Board Member | |
iTeos Therapeutics SA
iTeos Therapeutics SA Pharmaceuticals: MajorHealth Technology iTeos Therapeutics SA engages in the discovery of immunomodulators for cancer therapy. It operates as a biotechnology company which focuses on targeting metabolism of the tumor microenvironment through development of small-molecule immunomodulators for cancer treatment. The firm develops small molecules designed to target the tumor microenvironment by inhibiting cancer-induced immune suppression. Targeting such resistance mechanisms will enhance the clinical efficacy of both standards of care treatments as well as the newer immunomodulatory therapies based on the blockade of immune checkpoints. The company was founded in 2011 by Michel Detheux and Benoit Van den Eynde and is headquartered in Gosselies, Belgium. | Pharmaceuticals: Major | Director/Board Member | |
OBSEVA SA | Pharmaceuticals: Major | Director/Board Member | |
Edinburgh Business School | College/University | Masters Business Admin | |
Polyneuron Pharmaceuticals AG
Polyneuron Pharmaceuticals AG Pharmaceuticals: MajorHealth Technology Polyneuron Pharmaceuticals AG develops drugs for the treatment of autoimmune disorders. It develops drugs for the treatment of anti-MAG neuropathy disease and multifocal motor neuropathy disease. The firm also develops antibody-catch, a platform technology that enables the development of drugs for highly specific interception of autoimmune disease antibodies and focuses on autoimmune diseases of the peripheral nervous system that involve autoantibodies against carbohydrate epitopes. The company was founded by Andreas J. Steck, Beat Ernst, Pascal Hänggi and Ruben Herrendorffin in 2014 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
Vitaeris, Inc.
Vitaeris, Inc. BiotechnologyHealth Technology Vitaeris, Inc. develops new treatment options for chronic inflammatory diseases. The company was founded by Kevin Chow, Patrick A. Robinson and Noel F. Hall in 2016 and is headquartered in Vancouver, Canada. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
Fore Biotherapeutics, Inc.
Fore Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Fore Biotherapeutics, Inc. develops tumor specific driver mutations. It offers fully automated live-cell screening from NGS data. The company was founded by Haim Gil-Ad and Yoram Altschuler in 2011 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Director/Board Member | |
Oterittezrag Holding AG
Oterittezrag Holding AG Financial ConglomeratesFinance Oterittezrag Holding AG provides investment services. The private company is based in Zurich, Switzerland. | Financial Conglomerates | Director/Board Member | |
Hk Real Estate AG
Hk Real Estate AG Real Estate DevelopmentFinance Hk Real Estate AG is a Swiss company that buys and sells real estate properties. The private company is based in Zug, Switzerland. | Real Estate Development | Director/Board Member | |
Dren Bio, Inc.
Dren Bio, Inc. BiotechnologyHealth Technology Dren Bio, Inc. operates as a biotechnology company. It focuses on protein engineering technologies for depletion of cells, protein aggregates, and other disease-causing agents. The company was founded by John Wesley and Nenad Tomasevic in 2019 and is headquartered in San Carlos, CA. | Biotechnology | Director/Board Member | |
GALECTO, INC. | Pharmaceuticals: Major | Director/Board Member | |
ITEOS THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
MONTE ROSA THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Perseo pharma AG
Perseo pharma AG BiotechnologyHealth Technology Perseo pharma AG is a Swiss preclinical stage biopharmaceutical company that focuses on discovering and developing enzyme therapeutics for the treatment of digestive diseases. The company is based in Muttenz, Switzerland. The company has entered into a strategic research and development collaboration with Nestlé Health Science to develop novel therapies for digestive diseases. Perseo pharma's innovative technology is based on therapeutic enzymes that are protected in a nano shield with muco-adhesive coating. The company is a spin-off from the University of Applied Sciences (FHNW), School of Life Sciences in Switzerland, and was founded by Prof. Dr. Patrick Shahgaldian. Yves Dudal has been the CEO of the company since 2019. | Biotechnology | Director/Board Member | |
INOFEA AG
INOFEA AG Packaged SoftwareTechnology Services INOFEA AG is a Swiss biotech company founded in 2014 that works closely with its clients to provide them with a complex line of services that sustain their processes and products. The company is based in Muttenz, Switzerland. The company has developed a patented platform technology called enzzen® that empowers enzymes to fit industrial applications. Enzymes are protein molecules that carry a vital energy factor needed for every chemical reaction and reactions that occur in any living organism. INOFEA has successfully demonstrated the added-value of their technology for enzyme-mediated bioconjugation or post-translational modifications of antibodies or other large molecules. Anne Timm has been the CEO of the company since 2018. | Packaged Software | Director/Board Member | |
LONGBOARD PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member | |
Chairos AG | Director/Board Member | ||
Lescan Immobilien AG | Director/Board Member | ||
Regar Immobiliare AG | Director/Board Member | ||
IO BIOTECH, INC. | Biotechnology | Director/Board Member | |
Mahzi Therapeutics, Inc.
Mahzi Therapeutics, Inc. BiotechnologyHealth Technology Mahzi Therapeutics is a private biotechnology company that focuses on genetic therapies for rare genetic neurodevelopmental disorders. The company was founded by Yael Weiss and is based in San Mateo, CA. The company unites patient and family groups, academic researchers, diagnostic companies, other industry members, and its internal team of experts to develop therapies for patients with these serious diseases. Mahzi's team is experienced in all aspects of biopharmaceutical research, development, and manufacturing and is driven to make a difference in the lives of patients with rare genetic diseases. Yael Weiss has been the CEO since incorporation. | Biotechnology | Director/Board Member | |
River 2 Renal Corp.
River 2 Renal Corp. Pharmaceuticals: MajorHealth Technology River 2 Renal Corp. develops novel therapies targeting orphan diseases in the renal space. The private company is based in New York, NY. | Pharmaceuticals: Major | Director/Board Member | |
River 3 Renal Corp. | Director/Board Member | ||
CLEPSIDRA S.R.L. | Chief Executive Officer | ||
AdrenoMed AG
AdrenoMed AG Pharmaceuticals: MajorHealth Technology AdrenoMed AG develops a drug to decrease mortality in severe sepsis. The company was founded by Bernd Wegener, Gerald Heinz Möller and Andreas Bergmann in 2009 and is headquartered in Berlin, Germany. | Pharmaceuticals: Major | Director/Board Member | |
Southeastern Technology, Inc.
Southeastern Technology, Inc. Industrial MachineryProducer Manufacturing Part of NN, Inc., Southeastern Technology, Inc. operates as a contract manufacturer of machined components, assemblies, and engineered solutions for the medical device industry. The company is based in Murfreesboro, TN. Southeastern Technology was acquired by Autocam Medical Device Holdings LLC on December 02, 2014. | Industrial Machinery | Director/Board Member | |
Meili Peter Architeken AG | Director/Board Member |
Statistik
International
Schweiz | 23 |
Vereinigte Staaten | 19 |
Deutschland | 4 |
Dänemark | 3 |
Cayman Islands | 2 |
Sektoral
Health Technology | 26 |
Consumer Services | 7 |
Commercial Services | 4 |
Finance | 4 |
Electronic Technology | 2 |
Operativ
Director/Board Member | 84 |
Founder | 17 |
Corporate Officer/Principal | 15 |
Chief Executive Officer | 11 |
Independent Dir/Board Member | 10 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Beat R. Merz
- Unternehmensverbindungen